International
South Africa’s Afrigen eyes Ebola vaccine role after landmark GMP certification
Image via The Africa Report
Article Summary
46 words
As the Ebola outbreak in Democratic Republic of the Congo crosses into Uganda, South Africa’s Afrigen biotech laboratory is participating in proposals to develop an effective vaccine. This story was reported by The Africa Report. For more International news in Kenya, stay tuned to Masaa.
Continue Reading
Full story on The Africa Report
🔗 Clicking will take you to www.theafricareport.com
